Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical...

Area of Science:

• Precision medicine
• Pharmacogenetics implementation
• Genotype-guided prescribing

Background:

• Indiana University launched the Precision Health Initiative in 2019.
• The initiative aimed to increase the adoption of precision medicine, focusing on pharmacogenetics (PGx) implementation.
• The goal was to integrate genotype-guided prescribing into routine clinical care.

Purpose of the Study:

• To detail a multifaceted pharmacogenetics (PGx) implementation program.
• To describe interventions, challenges, and successes in adopting PGx into clinical practice.
• To guide other health systems in achieving sustainable PGx implementation.

Main Methods:

• Integrating PGx testing into existing healthcare systems.
• Implementing high-evidence drug-gene pairs and educating healthcare professionals.
• Engaging stakeholders, including patients, for result return optimization.
• Targeting underrepresented populations to reduce health disparities.
• Tracking third-party reimbursement for PGx testing.

Main Results:

• Successful integration of PGx testing into clinical workflows.
• Established educational programs for providers and pharmacists on PGx recommendations.
• Initiatives to optimize patient result return and engagement.
• Focused efforts on reducing health disparities through inclusive PGx testing.
• Monitoring of third-party reimbursement processes for sustainability.

Conclusions:

• The Indiana University Precision Health Initiative successfully implemented a comprehensive PGx program.
• Key strategies included system integration, education, stakeholder engagement, and health equity focus.
• The program's experience offers valuable insights for other institutions seeking sustainable PGx adoption.